4//SEC Filing
Williamson Douglas J 4
Accession 0001209191-23-008875
CIK 0001070494other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:45 PM ET
Size
8.3 KB
Accession
0001209191-23-008875
Insider Transaction Report
Form 4
Williamson Douglas J
Executive VP, Research & Dev
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2023-02-10+237,296→ 237,296 totalExercise: $18.97Exp: 2033-02-09→ Common Stock (237,296 underlying) - Award
Restricted Stock Units
2023-02-10+50,655→ 50,655 total→ Common Stock (50,655 underlying)
Footnotes (3)
- [F1]25% of the shares subject to the stock option vest on the first anniversary of February 10, 2023, with the balance vesting in 36 equal monthly installments thereafter, such that the shares subject to the option will be fully vested on the fourth anniversary of such date.
- [F2]Each restricted stock unit is subject to the 2023 Inducement Plan and represents a contingent right to receive one share of Acadia common stock.
- [F3]50% of the shares subject to the restricted stock units vest on the second anniversary of February 10, 2023, with the balance vesting in two equal annual installments thereafter, such that the shares subject to the restricted stock units will be fully vested on the fourth anniversary of such date.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001911501
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:45 PM ET
- Size
- 8.3 KB